ALZN
Alzamend Neuro·NASDAQ
--
--(--)
--
--(--)
ALZN fundamentals
Alzamend Neuro (ALZN) released its earnings on Sep 10, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -1.28 (YoY +88.62%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.28
+88.62%
Report date
Sep 10, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Alzamend Neuro (ALZN) key financial stats and ratios, covering profitability, financial health, and leverage.
Alzamend Neuro (ALZN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Alzamend Neuro (ALZN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Alzamend Neuro (ALZN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Alzamend Neuro (ALZN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Alzamend Neuro (ALZN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Alzamend Neuro next quarter?What is the revenue and EPS growth rate for Alzamend Neuro year over year?What is Alzamend Neuro's gross profit margin?What guidance did Alzamend Neuro's management provide for the next earnings period?What were the key takeaways from Alzamend Neuro’s earnings call?What factors drove the changes in Alzamend Neuro's revenue and profit?What does Alzamend Neuro do and what are its main business segments?What were the key takeaways from Alzamend Neuro's earnings call?
